Upstream Bio (UPB) Receivables - Net (2023 - 2026)
Upstream Bio (UPB) recorded quarterly Receivables - Net of $1.0 million in Q1 2026, up 54.79% quarter-over-quarter from $668000.0 in Q4 2025, and up 82.69% on a YoY basis from $566000.0 in Q1 2025.
Upstream Bio (UPB) Receivables - Net (2023 - 2026) Analysis & Trends
Upstream Bio's Receivables - Net history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 82.69% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 82.69% YoY), while the FY2025 annual figure was $668000.0, up 8.97% from the prior year.
- Receivables - Net was $1.0 million for Q1 2026 at Upstream Bio, up from $668000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $1.0 million in Q1 2026 to a low of $98000.0 in Q4 2023.
- Historically, Receivables - Net has averaged $611777.8 across 4 years, with a median of $613000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net jumped 525.51% in 2024, then grew 8.97% in 2025.
- A 4-year view of Receivables - Net shows it stood at $98000.0 in 2023, then surged by 525.51% to $613000.0 in 2024, then grew by 8.97% to $668000.0 in 2025, then jumped by 54.79% to $1.0 million in 2026.
- The last three Receivables - Net figures came in at $1.0 million (Q1 2026), $668000.0 (Q4 2025), and $683000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Upstream Bio | 339.03 Mn | 339.03 Mn | -3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 668,000.00 |
| Dec 31, 2025 | 668,000.00 |
| Sep 30, 2025 | 683,000.00 |
| Sep 30, 2025 | 683,000.00 |
| Jun 30, 2025 | 937,000.00 |
| Jun 30, 2025 | 937,000.00 |
| Mar 31, 2025 | 566,000.00 |
| Mar 31, 2025 | 566,000.00 |
| Dec 31, 2024 | 613,000.00 |
| Dec 31, 2024 | 613,000.00 |
| Sep 30, 2024 | 607,000.00 |
| Sep 30, 2024 | 607,000.00 |
| Dec 31, 2023 | 98,000.00 |
| Dec 31, 2023 | 98,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |